Netherton syndrome (NS; OMIM 256500) is an autosomal recessive disease regarded as one of the most severe heritable skin disorders af fecting newborns. NS involves both cutaneous and immunological abnormalities, including congenital ichthyosiform erythroderma, pro nounced peeling of the skin with detachment of the stratum corneum (SC) from the under lying epidermis, severe atopy with elevated serum IgE, and a characteristic hair shaft defect (Comel, 1949; Netherton, 1958; Judge et al., 1994; Hausser and AntonLamprecht, 1996) . Collec tively, these detriments represent a serious chal lenge to neonate health and promote frequent complications, including hypernatremic dehy dration, failure to thrive and recurrent bacterial infections that can be life threatening. Previ ously, we established that the defective gene in NS is SPINK5 (Chavanas et al., 2000) , which encodes the multidomain protease inhibitor, lymphoepithelial Kazaltype inhibitor (LEKTI). To date, the majority of SPINK5 mutations known to cause NS introduce a premature stop codon and result in a lack of detectable LEKTI expression (Hovnanian, 2013) .
NS has brought into sharp focus the need to preserve the balance between proteolysis and inhibition in the epidermis. Similarly, LEKTI has emerged as a key regulator of epidermal prote olysis. Synthesized as a large (145kD) polypro tein containing 15 Kazal domains, LEKTI is cleaved by furin to liberate a series of smaller fragments comprising one or more inhibitory units that target distinct protease subsets (Bitoun et al., 2003; Fortugno et al., 2011) . LEKTI of rapid dehydration (Yang et al., 2004; Descargues et al., 2005; Hewett et al., 2005) .
In this study, we developed a new transgenic murine model expressing human KLK5 in the GR of the epidermis to assess the role of this protease in NS. KLK5 has been reported to cleave several desmosomal cadherins in vitro (Caubet et al., 2004; Descargues et al., 2006) , to activate PAR2 in cultured keratinocytes (Stefansson et al., 2008) and has a prominent role in the proposed KLK proteolytic activation cascade (Brattsand et al., 2005) . This study reveals that elevated KLK5 expression, even in the presence of functional Lekti, is suffi cient to trigger the majority of the clinical hallmarks of NS. These findings establish the important role of KLK5 in NS pathophysiology and demonstrate its considerable potential as a therapeutic target in this severe genetic skin disorder.
RESULTS

KLK5 is overexpressed in the GR of Tg-KLK5 mice
KLK5 is one of several proteases known to be overactive in NS, but its precise role in the disease remains to be defined (Descargues et al., 2005 . To investigate the consequences of elevated KLK5 activity in vivo, we developed a transgenic murine model overexpressing human KLK5 under the control of the human involucrin promoter to target transgene expres sion in the GR of murine epidermis. The cDNA encoding human KLK5 full length sequence was fused to the FLAG tag and cloned downstream of the human involucrin promoter (Fig. 1 A) . Animals carrying the transgene were identified using a PCRbased genotyping strategy as shown in Fig. 1 B. Western blot analysis using an antihuman KLK5 antibody confirmed expression of the exogenous protein in epidermal extracts of TgKLK5 animals ( Fig. 1 C) . We identified this protein as being KLK5Flag by Western blot analysis with an antiFlag antibody (Fig. 1 E) . To confirm correct targeting of KLK5 to the GR, immunostaining of skin sections using the anti-human KLK5 antibody was performed. Murine Klk5 was detected at the GR-SC interface in WT epidermis, indicating cross reactivity of the human antibody with murine Klk5. In TgKLK5 epidermis, KLK5 staining was increased in the GR and SC, and faint in suprabasal cells (Fig. 1 D) . Detec tion of the FLAG epitope in TgKLK5 epidermis showed predominant expression of exogenous KLK5 in the GR and SC, and confirmed restricted expression of the transgene to the upper epidermis ( Fig. 1 F) .
Tg-KLK5 mice develop a skin barrier defect associated with growth delay, hair abnormalities, and constant scratching NS patients classically present at birth with scaling and general ized erythroderma (Hausser and AntonLamprecht, 1996) . At birth, TgKLK5 animals were slightly smaller than WT litter mates and showed mild erythroderma (Fig. 2 A) . TgKLK5 mice also showed significantly lower body mass than WT lit termates (Fig. 2 A) . To investigate epidermal barrier function in TgKLK5 mice, we first examined the ability of the skin to prevent penetration of an external dye solution in a whole mount assay. TgKLK5 neonates exhibited more patches of inhibits several members of the kallikreinrelated peptidase (KLK) serine protease family (KLK5, KLK7, and KLK14; Deraison et al., 2007; Fortugno et al., 2011) . Additionally, LEKTI has been recently suggested to inhibit caspase14 (Bennett et al., 2010) . Collectively, these proteases are known to hold prominent roles in the SC. KLK5, KLK7, and KLK14 contribute to desquamation by degrading desmosomal cad herins such as desmoglein1 and desmocollin1 (Caubet et al., 2004; Fortugno et al., 2011) whereas caspase14 is needed to complete the processing of filaggrin (Flg; Denecker et al., 2007; Hoste et al., 2011) . KLK5 and KLK14 are also able to stimulate proinflammatory and proallergic signals via protease activated receptor 2 (PAR2; Stefansson et al., 2008; Briot et al., 2009 ) and KLK5 and KLK7 are linked to the maturation of cathelicidin antimicrobial peptides (Yamasaki et al., 2006) . Thus, LEKTI coordinates the timing of several important proteolytic events in epidermal physiology and its absence in NS causes dysregulation of multiple pathways.
The development of Spink5deficient mice provided the first opportunity to unravel the complex pathophysiology of NS in an in vivo experimental model (Yang et al., 2004; Descargues et al., 2005; Hewett et al., 2005; Briot et al., 2009) . Spink5 / animals display a phenotype highly reminiscent of NS, replicating cutaneous and inflammatory aspects of the disease. Loss of LEKTI causes detachment of the SC from the underlying granular layer (GR) because of unopposed pro teolytic activity and premature degradation of desmosomes (Yang et al., 2004; Descargues et al., 2005) . Keratinocyte hyperproliferation, abnormal distribution of differentiation markers, accelerated Flg degradation, and lipid defects are also evident (Descargues et al., 2005; Bonnart et al., 2010) . Concurrently, uncontrolled proteolytic activity propagates acti vation of epidermal proinflammatory and proallergic signal ing pathways. In particular, proteolytic activation of PAR2 results in elevated expression of the proTh2 cytokine, thymic stromal lymphopoietin (TSLP), as well as several other proin flammatory and proallergic mediators (Briot et al., 2009) .
Despite the neonatal lethality of Spink5deficient mice (Yang et al., 2004; Descargues et al., 2005; Hewett et al., 2005) , considerable progress has been made on detailing the biologi cal pathways involved in NS pathophysiology. However, the significance of each protease implicated in the disease remains unclear. Loss of LEKTI leaves the activity of several proteases unopposed (Descargues et al., 2005; Deraison et al., 2007) , many of which are capable of degrading desmosomes or filag grin, and stimulating inflammation. Protease activation cas cades present an additional layer of complexity by providing an avenue for proteases not targeted by LEKTI to be involved in NS, such as matriptase (Sales et al., 2010) and elastase2 (ELA2; Bonnart et al., 2010) . These unknowns conceal the identity of the most promising pharmaceutical targets in NS and represent a major obstacle in developing targeted thera pies for NS and related skin disorders. Additionally, there is a current need to develop new animal models to study further aspects of NS pathophysiology, as Spink5 / mice uniformly do not survive for more than a few hours after birth because hair appeared thinner, lusterless, and spiky with flakes of dry skin on the fur. Cutting hair on the back revealed scaling un derneath the fur (Fig. 2 F, right) . Additionally, vibrissae were reduced, disoriented, bent, and short at birth (Fig. 2 G) . Con trary to body hair which showed a delay in growth but ap peared almost normal in nonlesional adult skin, whiskers stayed short and sparse as shown at 1 yr of age (Fig. 2 G) . Fi nally, subcutaneous lumps were noticed around the neck and on the legs of TgKLK5 mice (arrow; Fig. 2 H) . These cor responded to enlarged lymph nodes, which are examined in further detail below (see also Fig. 7 ).
hKLK5 expression triggers activation of the NS proteolytic cascade
In NS patients and Spink5deficient mice, LEKTI defi ciency leads to unopposed activity of several proteases, in cluding KLK5, KLK7, and ELA2 (Descargues et al., 2005 Bonnart et al., 2010) . To study whether overexpression of KLK5 led to global changes in skin proteolytic activity, we next analyzed protein extracts of adult skin by casein gel zymography. Several bands of proteolytic activity were detected and found to be enhanced in TgKLK5 extracts (31, 28, 23 , and 20 kD; Fig. 3 A) . These bands have previously been iden tified as KLK5 (31 kD; Descargues et al., 2005) , ELA2 (28 kD; Bonnart et al., 2010), and KLK7 (23-20 kD; Descargues et al., 2005) , whereas KLK14 has been shown to comigrate with KLK7 (Stefansson et al., 2006) . These data confirmed that heterologous KLK5 was active in TgKLK5 epidermis and led to the activation of several additional protease targets.
To further explore the in vivo proteolytic activation cascade propagated by KLK5, we used peptide substrates known to be cleaved by downstream KLK proteases (KLK7 and KLK14; blue staining compared with WT, mainly located on the neck, abdomen, muzzle, and ears, suggesting that the skin barrier was defective (Fig. 2 B) . To measure the extent of the skin barrier defect, we tested the ability of the skin to prevent fluid loss by measuring transepidermal water loss (TEWL). TgKLK5 neo nates showed significantly higher TEWL compared with wild type (Fig. 2 B) .
During the first week of life, TgKLK5 mice remained smaller than WT littermates with reduced body weight (Fig. 2 C) . They developed exfoliative erythroderma and scal ing of their entire body as shown at day 8 after birth in Fig. 2 (C and D). Their hair growth was also delayed (Fig. 2, C and D) . TEWL measurement revealed that the difference in barrier function between WT and TgKLK5 littermates had increased (Fig. 2 D) . Although the severity of the phenotype was vari able among TgKLK5 littermates, growth delay, erythro derma, scaling, and sparse fur were observed in all animals at 1 mo of age (Fig. 2 E) . To examine this further, we analyzed disease severity using an adapted Netherton area severity as sessment (NASA) scheme which is used in the clinic for NS patients (Oji et al., 2005) . Among TgKLK5 mice at 1 mo of age, extension of the lesions varied from localized on the head and trunk to more generalized lesions (head, trunk, back, and limbs). The severity of erythema varied between mild and severe, scaling between moderate and severe, and lichenifi cation (of the ears) between moderate and severe. Adult TgKLK5 mice showed normal size and body weight but developed intense and continuous scratching (varying from moderate to severe), resulting in chronic and extensive ero sions and crusts (Fig. 2 F, left) . Another feature of NS is hair defects (brittle and sparse hair), which we could examine in TgKLK5 mice as they survive the neonatal period. Body The human full-length KLK5 cDNA was fused at its 3 end with the FLAG epitope and cloned downstream of the regulatory sequences of the human IVL promoter. (B) Transgenic mice were discriminated from WT animals by genomic PCR using primers specific for the SV40 intron and the FLAG epitope (arrows in A). The Spink5 amplification was used as internal control. Transgenic KLK5 expression was confirmed by Western blot analysis using (C) anti-KLK5 and (E) antiFlag antibodies on adult skin protein extracts. Localization of (D) KLK5 and (F) Flag expression by immunohistochemistry on adult WT and Tg-KLK5 skin sections. Inserts at the bottom right of panel (D) and (F) show immunostaining with isotype controls. Bar, 25 µm.
In situ zymography using BODIPYFLcasein as a sub strate showed that epidermal proteolytic activity was confined to the SC in WT skin, and that this activity was increased and extended to the GR in TgKLK5 epidermis (Fig. 3 D) . These results confirmed that heterologous KLK5 was active in the most differentiated layers of TgKLK5 epidermis. Using BODIPYFLelastin as a substrate for in situ zymog raphy, ELA activity was restricted to the GR and SC in WT epidermis, whereas it was slightly elevated and extended to suprabasal layers in TgKLK5 (Fig. 3 E) . FITCgelatin in situ zymography showed low activity in WT epidermis, whereas activity was considerably increased in the GR and SC of TgKLK5 (Fig. 3 F) . In addition to increased proteolytic ac tivity in the epidermis of TgKLK5, caseinolytic, elastinolytic, de Veer et al., 2012 Veer et al., , 2013 . Cleavage of these substrates was elevated by more than twofold in TgKLK5 skin compared with WT (Fig. 3 B) . Although we cannot entirely exclude substrate processing by other proteases, these results demon strate that both trypsin and chymotrypsinlike proteolytic activities are increased in TgKLK5 skin.
Changes in MMP activity were also analyzed using gela tin gel zymography. Two groups of bands were detected, the lowest band for each being at 62 (MMP2) and 92 kD (MMP9). Therefore, it appeared that MMP2 activity was slightly lower and MMP9 activity was enhanced in TgKLK5 samples (Fig. 3 C) . The MW of these bands together with their sensitivity to EDTA identifies them as pro, intermediate, and active forms of MMP2 and MMP9. ( Fig. 4 A, bottom). On electron microscopy sections, abnormal detachment of cells was evident in TgKLK5 epidermis. Ultra structural analysis showed that desmosomes were not cohesive at the interface between the GR and SC (Fig. 4 B) . These structures were asymmetrically split with both dense plaques staying assembled. Contrary to Spink5 / skin in which many remnant nuclei and keratohyalin granules were observed in corneocytes (Descargues et al., 2005) , only mild parakeratosis, and no keratohyalin granules in the SC were observed after histological or electron microscopy analyses (Fig. 4 A) .
Several studies have shown that KLK5 is able to degrade desmoglein1 (Dsg1) and desmocollin1 (Dsc1) in vitro, and therefore is regarded to contribute to the detachment of superficial corneocytes during desquamation (Suzuki et al., 1993; Brattsand and Egelrud, 1999; Caubet et al., 2004) . We next analyzed the expression of the major desmosomal com ponents including Dsg1, Dsc1, and desmoplakin (Dsp). Im munostainings against Dsg1 and Dsc1 on WT epidermal and gelatinolytic activities were also increased in the dermis of these animals ( Fig. 3, D-F) . Overall, these data show that expression of hKLK5 in the GR of TgKLK5 mice is suffi cient to enhance KLK7, KLK14, and ELA2 activities in the epidermis, identifying KLK5 as an important contributor to the NS proteolytic cascade.
KLK5 hyperactivity causes SC detachment through desmosome cleavage NS patient skin shows characteristic acanthosis, hyperkerato sis, and SC detachment at the interface with the GR through desmosomal degradation. Histological analysis of TgKLK5 epidermis revealed intercellular separation at the GRSC boundary and detachment of the SC from the GR (Fig. 4 A, top). Compared with WT, TgKLK5 epidermis constantly showed marked acanthosis, papillomatosis and hyperkeratosis before SC detachment. Interestingly, hair follicles were sig nificantly reduced in number, hyperplastic and disorganized (A) Proteolytic activity in skin extracts from WT and Tg-KLK5 mice was examined by gel zymography using casein as an in-gel substrate. Areas of proteolytic activity are visible as clear bands against a dark background. The experiment shown is representative of five performed with three animals of each genotype. (B) Changes in proteolytic activity using a series of colorimetric substrates that target different proteases. Activity in WT and Tg-KLK5 extracts was detected by measuring absorbance at 405 nm after overnight incubation with substrates for either tryptic proteases (KLK5, KLK14, and matriptase), KLK7 or KLK14. Data are shown as the mean ± SEM of duplicates for four mice per genotype. The experiment shown is representative of three. P-values were calculated using the Mann-Whitney t test. **, P < 0.01 and ***, P < 0.001 comparing genotypes as indicated. (C) Gel zymography using gelatin as an in-gel substrate. The experiment shown is representative of five performed with three animals of each genotype. (D-F) The localization of proteolytic activity was analyzed by in situ zymography on cryosections of WT and Tg-KLK5 skin using internally quenched protein substrates. Cryosections were incubated with (D) BODIPY FL casein, (E) BODIPY FL elastin, or (F) FITC gelatin overnight and images were acquired using a Leica SP5 confocal laser scanning microscope. Fluorescence intensity data were transformed to a color gradient (as depicted) using ImageJ software. Dashed white lines represent the dermal-epidermal junction. The results shown are representative of experiments performed on at least five animals of each genotype. Bar, 25 µm.
sections revealed labeling limited to the cell border in the upper epidermis. In TgKLK5 epidermis, cell dissociation correlated with a marked reduction of Dsg1 and Dsc1 stain ings in suprabasal epidermis compared with WT (Fig. 4 , C and F). Western blot analysis confirmed a lower amount of Dsg1 in epidermal extracts from TgKLK5 mice (Fig. 4 D) . Transcript levels of Dsg-1 analyzed by quantitative RTPCR were not reduced in TgKLK5 compared with WT mice, supporting the notion that reduced Dsg1 expression resulted from proteolytic degradation (Fig. 4 E) . In Spink5 / mice, as well as in NS patients, we have previously shown that increased proteolytic activity leads to SC detachment at the GR-SC interface through degradation of Dsg1, Dsc1, and Dsp (Descargues et al., 2005 . However, in TgKLK5 epi dermis, Dsp was not affected by KLK5 hyperactivity (unpub lished data). Altogether, these data provide in vivo evidence that KLK5 hyperactivity initiates desmosomal component deg radation and detachment of the SC from the GR.
Tg-KLK5 mice show no evidence for abnormal epidermal terminal differentiation
In addition to premature desquamation, NS skin shows impaired terminal differentiation with lipid abnormalities (Descargues et al., 2005 Bonnart et al., 2010) . We next investigated epidermal terminal differentiation markers including involu crin, loricrin, and Flg in the epidermis of TgKLK5 mice. In volucrin, which is an early marker of cornification, was expressed in the upper spinous layer and in the GR of WT epidermis (Fig. 5 A) . In TgKLK5 epidermis, involucrin showed the same pattern of expression but appeared to be extended due to acanthosis (Fig. 5 A) . Immunostaining of loricrin, a later marker of cornification, was restricted to the upper GR and was not different between WT and TgKLK5 (Fig. 5 B) . Flg, which is mainly present in the GR and SC of WT epidermis, showed the same pattern of expression in TgKLK5 epidermis (Fig. 5 C) , unlike Flg overdegradation in Spink5 / and TgELA2 epidermis (Descargues et al., 2005; Bonnart et al., 2010) . By Western blot analysis, no dif ference could be detected in Flg processing between WT and TgKLK5 (Fig. 5 D) . We conclude that the skin barrier defect in TgKLK5 mice is not associated with an abnormal differ entiation pattern.
In adult WT and TgKLK5 epidermis, nile red staining revealed uniform, linear lipophilic structures corresponding to corneocyte intercellular spaces. In WT, staining was thin and corresponded to the SC. In TgKLK5, multiple layers were seen, corresponding to hyperkeratosis (Fig. 5 E) . Con trary to Spink5 / and TgELA2 skin, no lipid droplets were observed in TgKLK5. Oil Red O, specific for free fatty acids, triglycerides, and esterified cholesterol showed staining only results demonstrate that KLK5 overexpression does not alter terminal differentiation reflected by differentiation marker expression or lipid abnormalities.
KLK5 hyperactivity leads to cutaneous signs of allergy and inflammation
Uncontrolled proteolytic activity in NS leads to persistent ac tivation of inflammatory signaling pathways in the epidermis. In NS epidermis, we previously uncovered a cellautonomous process in which KLK5 directly activates PAR2 and induces NFB-mediated overexpression of thymicstromal lympho poietin (TSLP), intracellular adhesion molecule (ICAM1), TNF, and IL8 (Briot et al., 2009) . Furthermore, Spink5 / grafted skin is rich with proinflammatory and proallergic in the SC for both WT and TgKLK5 animals with no ab normal deposition in the skin (Fig. 5 F) . Filipin, specific for unesterified cholesterol, intensely stained the SC in both WT and TgKLK5 animals (Fig. 5 F) . Increased intensity of staining in TgKLK5 for Oil Red O and filipin could be attributable to marked hyperkeratosis (Fig. 5, F and G) .
As epidermal lipid composition analysis requires isolation of the epidermis from the dermis, we used skin samples from 8dold mice, before hair emerges from the skin, for high performancethin layer chromatography (HPTLC). At this stage of analysis, hyperkeratosis is not as pronounced as in adult skin. No difference in lipid composition for triglycer ides, free fatty acids, cholesterol, and ceramides was observed between WT and TgKLK5 at day 8 (Fig. 5 H) . Overall, these ( Fig. 6 F) . CCL17/TARC and CCL22/MDC are major pro Th2 mediators that can recruit proallergic Th2 cells via the chemokine receptor CCR4 to the skin (Homey and Zlotnik, 1999) . In TgKLK5 skin, Ccl17 and Ccl22 mRNA levels showed a slight increase (Fig. 6 F) . In contrast, Ccl8 (known to attract actors of allergy and inflammation) and Ccl20 (a chemoattractant for Th17 cells) showed significantly ele vated expression in TgKLK5 skin (Fig. 6 F) . In addition, TgKLK5 skin showed elevated expression of Il6, Il18, and Il23 (Fig. 6 G) .
Among the allergy/atopyassociated Th1/Th2 and Th17/ Th22 cytokines, Il4, Il17, and Il22 mRNA levels showed a significant increase in the skin of TgKLK5 mice (Fig. 6 H) . Additionally, genes known to be upregulated by Th17 such as Defb4 and Cxcl1 (Nograles et al., 2008) showed elevated expression at the mRNA level in TgKLK5 skin (Fig. 6 I) . IL17 and IL22 are known to upregulate the expression of S100A7, S100A8, and S100A9 in human keratinocytes (Boniface et al., 2005; Nograles et al., 2008) . Increased levels molecules and is highly infiltrated by activated mast cells and eosinophils (Briot et al., 2009 ). TgKLK5 nonlesional skin re produced similar abnormalities, including infiltrates of T cells, mast cells and presence of eosinophil granulocytes in the der mis whereas none could be seen in WT (Fig. 6, A-C) .
Disruption of the epidermal barrier stimulates elevated expression of an array of proinflammatory cytokines and activates signaling pathways that modulate keratinocyte differ entiation and the immune response. To profile the proinflam matory environment induced by KLK5 hyperactivity, we performed a targeted transcript analysis using qRTPCR. First, we examined the expression of prominent proinflam matory and proallergic cytokines in WT and TgKLK5 non lesional skin. Expression of the proTh2 cytokine Tslp, was significantly increased in TgKLK5 skin, both at the mRNA and protein level (Fig. 6, D and E) . Additionally, Tnf, Il1, and Icam1 were all significantly increased at the mRNA level (Fig. 6 E) . We next investigated the expression of mole cules which are known to attract immune cells to the skin Insets at the bottom right show isotype controls. Stainings are representative of experiments performed three times with five animals of each genotype. (E-I) Relative mRNA expression of proinflammatory and proallergic cytokines and chemokines analyzed by quantitative RT-PCR on RNA extracted from adult nonlesional Tg-KLK5 skin and WT skin. Data are shown as the mean ± SEM of triplicate amplification for at least six mice per genotype. Results are normalized to WT mean (set as 1.0). P-values were calculated using the Mann-Whitney t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001. The experiment was performed three times. display key features of NS but die shortly after birth (Yang et al., 2004; Descargues et al., 2005; Hewett et al., 2005) . Here, we developed a new model of NS by overexpressing KLK5 in the epidermis. These mice allowed us to both decipher the role of KLK5 hyperactivity in NS pathogenesis in vivo, and to provide a new and viable model to study further aspects of NS physiopathology, particularly those that become promi nent after birth. We provide evidence here that overexpression of KLK5 in the epidermis leads to the development of the major NS hallmarks, confirming the role of KLK5 as a key contributor to the NS proteolytic cascade. In addition, we provide a new and viable mouse model recapitulating the hallmarks of NS.
In NS, the absence of LEKTI has been shown to result in unopposed activity of several proteases (Descargues et al., 2005 Bonnart et al., 2010) . We show here that over expression of human KLK5 in murine epidermis triggers major enhancement of the global proteolytic activity in the skin that overcomes the inhibitory capacities of Lekti. As our construct expresses KLK5 as a proprotease, this implies that it has been activated in vivo. It has recently been shown that matriptase can activate proKLK5 and proKLK7 in vitro (Sales et al., 2010) . KLK5 has been shown to activate pro KLK7, proKLK14, and proELA2, as well as to amplify cas cade initiation by activating proKLK5 in vitro (Brattsand et al., 2005; Bonnart et al., 2010) . Using gel zymography and peptide substrates, we have shown that not only KLK5 activ ity but also KLK7, KLK14, and ELA2 activities were increased in TgKLK5 skin. These results provide in vivo evidence that KLK5 can indeed activate KLK7, KLK14, and ELA2 as described by in vitro experiments (Brattsand et al., 2005; Bonnart et al., 2010) . In addition, we observed an increase in MMP9 activity in TgKLK5 skin. It is to our knowledge the first description of a functional link between MMP9 and KLK5, which is potentially mediated by PAR2 activation as demonstrated in transgenic CAP1/Prss8 Par2deficient mice (Frateschi et al., 2011) .
NS patients suffer from a profound skin barrier defect. Histopathologic examination of NS skin reveals a psoriasi form epidermis, associated with hyperkeratosis, hyperplasia of the subcorneal epithelium (acanthosis), and varying degrees of epidermal invaginations into the dermis (papillomatosis; Hausser and AntonLamprecht, 1996) . These observations are consistent with the fact that skin barrier defects can induce compensatory hyperproliferative mechanisms resulting in hyperkeratosis and acanthosis. Another feature of NS epidermis is premature detachment of the SC from the GR as a result of desmosome cleavage (Descargues et al., 2005 . These features are all seen in TgKLK5 skin, including marked acan thosis, papillomatosis, and hyperkeratosis before SC detach ment. Interestingly, IL22, which is increased in chronic stages of atopic dermatitis induces epidermal hyperplasia (Nograles et al., 2008) . The increased Il22 expression observed in Tg KLK5 skin could thus contribute to acanthosis. In TgKLK5 skin, the SC detachment occurs at the SC-GR interface as a result of desmosome cleavage through Dsg1 and Dsc1 of Il17 and Il22 transcripts in TgKLK5 skin coincided with significant increases in S100a7, S100a8, and S100a9 mRNA expression (Fig. 6 I) . Finally, the expression of genes upregulated by Th1/IFN such as Ccl5, Cxcl9, Cxcl10, and Cxcl11 were all considerably reduced in TgKLK5 skin (Fig. 6 I) .
Collectively, these data demonstrate that dysregulated KLK5 activity in the skin is sufficient to induce cutaneous allergic inflammation. This involves upregulation of Tslp, Icam1, and Tnf and the production of chemokines known to attract mast cells, eosinophil granulocytes, and Th2/Th17/ Th22 cells involved in allergy and inflammation.
KLK5 hyperactivity triggers systemic allergy and inflammation NS is a severe disease that is associated with a broad spectrum of severe atopic manifestations with high IgE levels. TSLP has been shown to be elevated in the serum of children with atopic dermatitis (Lee et al., 2010) . Increased Tslp expression in TgKLK5 skin led us to investigate the expression of this major proTh2 cytokine in the serum of adult TgKLK5 mice. Tslp levels were significantly elevated in the serum of TgKLK5 as compared with WT mice (Fig. 7 A) . Addition ally, we found significantly increased levels of total IgE in TgKLK5 serum, and elevated total IgG, mainly due to in creased IgG1 (Fig. 7 B) . We next examined the morphology of lymphoid tissues including the spleen, thymus, and draining lymph nodes (cervical and inguinal). The spleen and lymph nodes were enlarged in TgKLK5 mice, whereas the thymus appeared slightly smaller (Fig. 7 C) . Lymph node enlargement resulted from hyperplasia as shown by the increase in the number of cells in inguinal nodes (Fig. 7 D) .
The proTh2 cytokine TSLP, which is highly expressed in the skin and the serum of TgKLK5 mice, is known to induce a proallergic microenvironment and to promote the differ entiation of T helper (Th) 0 cells into proallergic Th2 cells (Soumelis et al., 2002) . This led us to investigate whether T cells isolated from lymph nodes were Th1, Th2, and/or Th17 biased in TgKLK5. Phenotyping the cell populations from draining lymph nodes revealed an increased number of B cells, monocytes, dendritic cells, and T lymphocytes (unpub lished data). Of the CD4 + T cells isolated from lymph nodes, a higher proportion were IL4 + , IL13 + , TNF + , and IL17 + -producing T cells as compared with WT (Fig. 7 E) . Collectively, these data establish that the effects of KLK5 hyperactivity are not restricted to the skin. Indeed, overexpression of the pro tease specifically in the epidermis led to the production of allergy markers found in the serum and to the expansion of activated T cells in draining lymph nodes, as a consequence of skin inflammation and allergy.
DISCUSSION
Netherton syndrome (NS) is a rare autosomal recessive skin disease with severe skin inflammation and scaling, a specific hair shaft defect and constant allergic manifestations. We and others previously described Spink5deficient mice, which not observe major alterations in either epidermal terminal differentiation or Flg processing in TgKLK5 mice, even though ELA2 activity was increased. One possibility could be that ELA2 activity did not reach the level of activation observed in the TgELA2 murine model as suggested by comparative elastin in situ zymography between TgELA2 and TgKLK5 (unpublished data). Consistent with this, kera tohyalin granules in TgKLK5 were still present, in contrast to TgELA2 where they were absent (Bonnart et al., 2010) . Re cently, KLK5 was shown to directly process proFlg in vitro degradation as previously demonstrated in NS skin (Descargues et al., 2005 . NS skin also exhibits impaired epidermal differentiation, with increased involucrin and loricrin expres sion, fewer keratohyalin granules, decreased Flg immuno staining in the GR and abnormal lipid structure and composition (Descargues et al., 2005 Bonnart et al., 2010) . We have previously shown that ELA2 is hyperactive in NS skin and that transgenic mice overexpressing ELA2 in the GR displayed abnormal (pro) Flg processing and impaired lipid lamellae structure (Bonnart et al., 2010) . Of note, we did Spink5 / skin grafts (Briot et al., 2009 ). These features of se vere cutaneous inflammatory and atopic manifestations are prominent in TgKLK5 mice. Our results establish that KLK5 overactivity in murine epidermis is sufficient to induce a pro allergic and proinflammatory environment.
In skin of atopic dermatitis patients, TSLP expression is associated with the migration of Langerhans cells to the draining lymph nodes. TSLPactivated dendritic cells have been shown to induce naive T cells to differentiate into "allergic" Th2 cells producing IL4, IL5, IL13, and TNF (Soumelis et al., 2002) . We have previously shown that NS keratinocytes show high expression of TSLP (Briot et al., 2009) . Consistent with this observation, we showed that TSLP expression was also strongly enhanced in TgKLK5 skin. Normal human keratinocytes do not express detectable levels of TARC and MDC, contrary to NS and AD keratinocytes (Horikawa et al., 2002; Tsuda et al., 2003; Briot et al., 2009 ). These two chemokines can recruit Th2 cells via CCR4 to the skin, defining them as major proTh2 mediators (Homey and Zlotnik, 1999) . In NS keratinocytes, we have previously shown that MDC and TARC are not induced by KLK5 and PAR2 activation (Briot et al., 2009) . We have confirmed this observation in vivo because TgKLK5 skin exhibits only a slight increase of these two chemokines. However, the pres ence of IL4 in TgKLK5 skin reflects the presence of Th2 cells. This suggests that slightly elevated Mdc and Tarc levels, when combined with the inflammatory environment are sufficient to recruit Th2 cells to the skin of TgKLK5 mice.
We also uncovered the presence of Th17 and Th22 cells in TgKLK5 skin. In inflammatory diseases, such as psoriasis, it has been shown that the presence of "inflammasome related" cytokines such as IL1 and IL18 could synergize with IL23 to promote Th17 cell differentiation (Mills et al., 2013) . In TgKLK5 skin, we found elevated expression of Il1, Il18, and Il23, which could explain the presence of Th17 cells. The treatment of healthy keratinocytes with TNF in duces the expression of CCL20, a molecule involved in Th17 recruitment (KennedyCrispin et al., 2012) . It is thus possible that enhanced Tnf and Il1 production in TgKLK5 con tributes to Ccl20 expression leading to Th17 recruitment. Of note, IL17 has been shown to induce the secretion of pro inflammatory cytokines (IL1 and IL6), antimicrobial pep tides, and several chemokines including IL8 and CCL20 in human keratinocytes. In addition, the induction of CCL20 by keratinocytes has been suggested as a mechanism that maintains Th17 cells in skin (Perera et al., 2012) . We have also found increased expression of Defb4, Cxcl1, S100a7, S100a8, and S100a9 in TgKLK5 skin, which are genes known to be induced by Il17 and Il22. A similar inflammatory profile is found in atopic dermatitis in which, in addition to Th2, Th22 and Th17 play important roles in the pathogenesis of the dis ease SuárezFariñas et al., 2013) . These observations support the contribution of Th17 and Th22 cells to skin inflammation in the TgKLK5 murine model.
Unlike Spink5 / mice, TgKLK5 mice are viable, which allowed us to investigate signs of allergy in the serum. We (Sakabe et al., 2013) . The fact that no significant decrease in proFlg was observed in TgKLK5 animals suggests that regu lation of proFlg processing by KLK5 is more complex and involves additional factors in vivo. The presence of Lekti in TgKLK5 mice could imply that KLK5 and other proFlg processing proteases, such as caspase 14, remained sufficiently regulated during terminal differentiation to prevent Flg over degradation. The observation that TgKLK5 mice reproduce major abnormalities of NS supports an important role for KLK5 in the disease. However, not all features are observed, suggesting that additional proteases could be involved in the complete phenotype.
NS patients show failure to thrive in infancy and short stature. In a similar way, TgKLK5 mice displayed a lower weight at birth and a growth delay. However, this delay was only transient and mice had a nearly normal weight and size at 2 mo of age. Several KLKs, including KLK5, are known to cleave growth hormone (GH) and to be present in the pitu itary gland (Komatsu et al., 2007) . It has been suggested that in NS patients the absence of LEKTI leads to higher proteo lytic processing of GH, which may become biologically inac tive (Komatsu et al., 2007) . As we do not expect transgene expression in the pituitary gland and Lekti is still present in TgKLK5, it is possible that other factors contribute to the growth delay in TgKLK5 mice. Another characteristic fea ture of NS patients is a specific hair shaft defect (trichor rhexis invaginata) that leads to sparse, brittle, and spiky hair. In TgKLK5 animals, we observed an apparent thinning of body hair, which had a lusterless and spiky appearance. As in new born Spink5 / mice (Descargues et al., 2005) , TgKLK5 whis kers were scarce, disoriented, bent, and short. Existing murine models such as Cathepsin L / or Matriptase / have shown that hair follicle morphogenesis is a proteasedependent pro cess (Roth et al., 2000; List et al., 2002) . This viable murine model will allow the mechanisms underlying hair follicle ab normalities in NS to be deciphered.
In NS patients, atopic features with elevated IgE are con stant during infancy and adulthood. These include eczematous like lesions, allergic asthma, allergic rhinitis, urticaria, and angiodema (Sun and Linden, 2006) . Only a few immunologi cal studies have been reported in NS patients to date (Judge et al., 1994; Stryk et al., 1999; Renner et al., 2009) . In these studies, a constant finding is elevated specific IgE levels to common allergens, although a proallergic Th2 skew has not been consistently found. Studies on Spink5 / skin have been limited to grafting experiments on WT mice and have shown enhanced expression of proinflammatory cytokines, such as Il1, Tnf, IL8, and Icam1 and proallergic mediators, such as Tslp, Ccl17 (Tarc), and Ccl22 (Mdc; Briot et al., 2009) . We have previously shown that increased TNF, IL8, ICAM1, and TSLP expression is an intrinsic property of NS kera tinocytes as a result of the KLK5-PAR2-NFB pathway (Briot et al., 2009) . The proinflammatory and proallergic cy tokines overexpressed in NS epidermis play an active role in recruiting inflammatory cells to the skin, including mast cells and eosinophils whose numbers are significantly increased in Committee on Standardized Genetic Nomenclature for Mice. Transgenic mice were named TgKLK5 for the following study. TEWL measurement. TEWL was measured using an EP1 evaporimeter (ServoMed) as previously described (Descargues et al., 2005) .
Barrier function assay. Euthanized newborn mice were immediately sub jected to graded methanol dehydration and subsequent rehydration as pre viously described (Ekholm et al., 2000) . Pups were then washed in PBS for 1 min, stained in 0.1% toluidine blue (SigmaAldrich) for 1 h at room tem perature, destained for 15 min in PBS, and analyzed.
RNA isolation, RT, and quantitative real-time PCR. Murine skin was crushed in RLT buffer (QIAGEN) using an UltraTurax, after which RNA was isolated using the RNeasy mini kit (QIAGEN). Complementary DNA was synthesized by reverse transcription from 1 µg total RNA using MMLV Re verse transcription (Invitrogen). Quantitative realtime PCR was performed on an ABI prism 7500 Sequence Detection system (Applied Biosystems) using qPCR MesaGreen Mastermix (Eurogentec). The expression of target genes was normalized to murine hypoxanthine phosphoribosyl transferase (Hprt). Primer sequences can be obtained on request from the authors. Data were analyzed using 7500 software v2.0.6. (Applied Biosystems).
Antibodies. Antibodies used for Western blot analysis and immunohisto chemistry were: Actin (A5441; SigmaAldrich), Flag (F7425; SigmaAldrich); Desmocollin1 (sc18115; Santa Cruz Biotechnology, Inc.); Desmoglein1 (sc20114; Santa Cruz Biotechnology, Inc.); Flg (PRB417P; Covance); KLK5 (ab7283; Abcam); Involucrin (sc15230; Santa Cruz Biotechnology, Inc.); Loricrin (PRB145P; Covance); TSLP (AF555; R&D Systems); and CD3 (ab5690; Abcam).
Western blotting. For Western blot analysis, skin was crushed in protein extraction buffer (50 mM TrisHCl, pH 8.5, 5 mM EDTA, 150 mM NaCl, 0.1% NonidetP40, and Protease Inhibitor Cocktail Tablets [Complete, Roche]) using an UltraTurax. Lysates were clarified by centrifugation (13,000 g, 4°C for 30 min) to remove insoluble material. For Flg Western blot analysis, pro teins were extracted using 50 mM TrisHCl, pH 8.0, 8 M urea, 10 mM EDTA, and Protease Inhibitor Cocktail Tablets. Protein content in each sam ple was measured by Bradford assay (BioRad Laboratories) according to the manufacturer's instructions. Protein fractions were mixed with Laemmli buf fer, incubated for 5 min at 90°C, and then separated by SDSPAGE. For KLK5, Flag, and Dsg1 Western blots, 5 µg of proteins (for Flg, 1.5 µg of proteins) were loaded on a 4-12% precast gel (Invitrogen). After migration, proteins were transferred to HybondECL membranes (GE Healthcare). After incu bation with primary and secondary antibodies, enhanced chemiluminescence detection was performed as recommended by the manufacturer (Thermo Fischer Scientific).
In situ zymography. Skin cryosections (5µm thickness) were mounted on glass slides, rinsed with 2% Tween 20 in PBS and incubated at 37°C over night with 10 µg ml 1 BODIPY FL casein (Life Technologies), 100 µg ml 1 BODIPY FL elastin (Life Technologies) or 4 µg ml 1 FITCgelatin (Life Technologies) in 50 mM TrisHCl, pH 8.0. Sections were rinsed with PBS and visualized using a Leica TCS SP5 AOBS confocal microscope. Data were analyzed using ImageJ (National Institutes of Health) software.
Proteolytic activity assays. For proteolytic activity assays, skin was crushed in 1 M acetic acid using an UltraTurax. After overnight extraction at 4°C, insoluble material was removed by centrifugation (13,000 g, 4°C for 30 min) and the supernatant was dried using a SpeedVac. Proteins were resuspended in water overnight at 4°C and clarified by centrifugation (13,000 g, 4°C for 30 min). Protein content was determined by Bradford assay (BioRad Laboratories).
For gel zymography, 10 µg of protein extracts were loaded onto casein/ acrylamide copolymerized gels (15% acrylamide, 0.1% casein; SigmaAldrich)
found elevated Tslp and IgE concentrations that reflect the Th2 cytokinemediated IgE class switch of B cells. Thus, our results show that the effects of dysregulated KLK5 activity are not restricted to TgKLK5 skin. In TgKLK5 mice, con tinuous scratching led to alopecic, erosive, and crusty skin le sions. These observations are highly relevant to NS patients who show constant, often severe and disabling pruritus. Per sistent itch causes sleeplessness and scratching, which further aggravate skin lesions. A wellestablished mediator of itching is PAR2 activation (Steinhoff et al., 2003) . Several serine pro teases capable of activating PAR2 are present in TgKLK5 skin, including KLK5, KLK14 in the epidermis, and tryptase from infiltrating mast cells. TgCAP1/Prss8 mice display a similar itchy phenotype, which could be rescued by PAR2 knockdown (Frateschi et al., 2011) . In TgKLK7 mice, which develop chronic dermatitis, itching does not respond to anti histamine therapy and is also potentially attributable to PAR2 activation (Hansson et al., 2002) .
In summary, we have generated a new and viable murine model that recapitulates the major cutaneous and systemic hallmarks of NS and validates KLK5 as a promising target for NS treatment. Accordingly, successful inhibition of KLK5 has the potential to reduce the skin barrier defect as well as features of inflammation and allergy. Furthermore, this model will allow the study of further aspects of NS pathophysiology that are currently not well understood, such as growth delay, immune system dysregulation, and hair defects. It will also be instrumental for preclinical testing of therapies for NS and related diseases that involve a skin barrier defect and severe atopic manifestations. Indeed, atopic dermatitis shows several similarities with NS, including increased skin barrier permea bility and elevated TSLP, which lead to a Th2biased response and high serum IgE. Collectively, our results show that the TgKLK5 murine model shares important similarities with human atopic dermatitis. Therapies aiming at controlling these dysregulated pathways could be evaluated in vivo using the TgKLK5 murine model.
MATERIALS AND METHODS
Generation of KLK5 transgenic mice. This work was approved by the Commission de Génie Génétique (01-1008, agreement number 4858) and all experiments were performed in accordance with the required guidelines and regulations. The fulllength cDNA encoding human KLK5 (I.M.A.G.E. clone 100020682) was amplified by RTPCR. The FLAG octopeptide epi tope was added to the 3 end of the resulting product followed by NotI restriction sites to both ends. After digestion with NotI, this construct was inserted into the IVL promoter vector (pH3700pL2; gift from J. Segre, National Human Genome Research Institute, Bethesda, Maryland; Carroll and Taichman, 1992; Carroll et al., 1993) and validated by sequencing. The transgene (comprising the IVL promoter and human KLK5 FLAG construct) was excised from pH3700pL2 by digestion with SalI, purified and injected into the pronuclei of fertilized oocytes from (C57BL/6 x CBA) F1 mice, and finally implanted into pseudopregnant females. First generation offspring were genotyped by isolating genomic DNA from mouse tail samples using the Nucleospin Tissue kit (MachereyNagel) and performing PCR using allelespecific primers designed to detect the transgene or an internal PCR control. The founder mouse was crossed and backcrossed with wildtype C57BL/6 animals to establish the transgenic line according to the International IgE antibody (1/2000; Southern Biotech). Signal was developed by addition of streptavidinHRP conjugate (1/2000; Interchim). All samples were ana lyzed in duplicate or triplicate by measuring the absorbance at 450 nm using a microplate reader (Versamax; Molecular Devices). Concentrations were cal culated using standard curves generated with known dilutions of mouse IgG, IgG2a, IgG1 (Southern Biotech), and IgE (BD).
Flow cytometry. Singlecell suspensions were prepared from inguinal lymph node extracts. Surface antigen staining was performed using the fol lowing antibodies (eBioscience): antiCD45 (clone 30F11), antiCD4 (clone RM45), antiCD8 (clone 53-6.7), and antiTCR (clone H57597). For intracellular cytokine staining, isolated cells were activated in complete RPMI containing 0.5 µg ml 1 phorbol 12 myristate 13acetate (PMA), 0.5 µg ml 1 ionomycin and 10 µg ml 1 brefeldin A (all from SigmaAldrich) for 4 h. After surface staining, cells were fixed and permeabilized using Cyto fix/Cytoperm solution (BD). Cells were washed in perm/wash buffer and incubated for 30 min at 4°C with different antibody combinations specific for murine cytokines (all from eBioscience) diluted in perm/wash buffer: antiIl4 (clone 11B11), anti-IL13 (clone eBio13A), antiIl17 (clone eBio17B7), and TNF (clone MP6XT22). Immunostained cells were analyzed by flow cytometry using a FACS Aria flow cytometer (BD).
Statistical analysis.
Experiments were repeated at least three times and pvalues were calculated using the MannWhitney t test. P < 0.05 was con sidered significant. or gelatin/acrylamide copolymerized gels (10% acrylamide and 0.1% gela tin; SigmaAldrich) for electrophoresis. After separation by SDSPAGE, gels were washed with 2.5% Triton X100 (two times for 30 min) and incubated for 24 h at 37°C in reaction buffer (50 mM TrisHCl, pH 8.0). Buffer for gelatin zymography additionally contained 10 mM CaCl 2 . Gels were stained with 1% Coomassie Brilliant blue G250.
Additionally, proteolytic activity was assessed using colorimetric peptide substrates that are preferentially cleaved by different proteases. Acetic acid skin extracts (25 µg) were added to assay buffer (0.1 M TrisHCl pH 8.0, 0.005% Triton X100, 0.05% sodium azide) in 96well plates (final volume 200 µl). Substrates used were 150 µM AcYASRpNA (cleaved by several trypsinlike serine proteases including KLK5, KLK14 and matriptase), 150 µM KHLYpNA (cleaved by KLK7) and 150 µM AcWAVRpNA (cleaved by KLK14; de Veer et al., 2012 de Veer et al., , 2013 . Plates were incubated at 37°C overnight and activity was analyzed by measuring the increase in absorbance at 405 nm compared with substrate only controls.
Histological, immunohistochemical, and immunofluorescence analysis. Skin samples were snap frozen in liquid nitrogen in TissueTek O.C.T. (Thermo Fischer Scientific) or fixed in 10% buffered formalin and embed ded in paraffin. Hematoxylin/eosin/safranin, toluidine blue, and luna staining were performed on paraffinembedded sections using standard histological techniques. For antigen retrieval, paraffinembedded sections were boiled in 10 mM citrate buffer, pH 6.0, for 20 min ( Flg or TSLP immunostaining) or treated with S1700 solution (Dako) for 45 min (KLK5, Flag, Involucrin, or Loricrin immunostaining). Desmoglein1, Desmocollin1, and CD3 immuno histochemistry was performed on skin cryosections. Signal was detected using the appropriate horseradish peroxidase (HRP)-conjugated polymer (En Vision System; Dako).
Transmission electron microscopy analysis. Skin samples were fixed in 4% paraformaldehyde and 2% glutaraldehyde, rinsed in Sorensen buffer, post fixed in 2% aqueous OsO 4 , dehydrated in graded ethanol solution, and em bedded in epon. Ultrathin sections were counterstained with uranyl acetate and lead citrate. Examination was performed with a 1011 transmission elec tron microscope (Jeol Inc., Japan). Acquisition and processing were performed with an Erlangshen CCD camera (Gatan Inc.) and Digital Micrograph soft ware (Gatan Inc.).
Lipid analyses. For nile red staining, cryosections were incubated with 2.5 µg ml 1 nile red in 75% glycerol for 5 min and mounted. Filipin staining was performed on cryosections using 50 µg ml 1 filipin in 75% glycerol and 25% water (30 min incubation). Slides were rinsed twice with PBS and mounted with aqueous mounting medium. For Oil Red O staining, cryosections were incubated for 10 min in 60% isopropanol followed by staining with 0.3% (wt/vol) Oil Red O in 60% isopropanol (20 min). Sections were subsequently rinsed with water and mounted with aqueous mounting medium. Filipin and nile red stainings were visualized using a Leica TCS SP5 AOBS confocal microscope and data were analyzed using ImageJ. Oil Red O stainings were visualized using a whitelight microscope. Lipid composition analysis was performed using HPTLC as previously described (Bonnart et al., 2010) .
Measurement of serum TSLP and immunoglobulin levels. Sera were analyzed by ELISA for TSLP, total IgG, IgG1, IgG2a, and IgE levels. Serum TSLP was measured using the murine TSLP Quantikine ELISA kit (R&D Sys tems) according to the manufacturer's instructions. For immunoglobulin analy sis, ELISA plates were coated overnight with rat anti-mouse IgG (2.5 µg ml 1 , LOMGCOC2), IgG1 (1.25 µg ml 1 , LOMG113) or IgG2a (5 µg ml 1 , LOMG2a7) antibodies (Southern Biotech). Plates were blocked with 1% BSA in PBS and incubated with serial dilutions of mouse sera, followed by antiIg PO HRPconjugated secondary (1/2000, Southern Biotech). Signal was developed by incubation with 3,3,5,5-tetramethylbenzidine substrate (Fluka). For IgE, plates were coated overnight with 3 µg ml 1 rat anti-mouse IgE (LOME3), blocked with 1% BSA in PBS, and incubated with serial dilutions of mouse sera, followed by biotinylated rat anti-mouse
